Helicobacter pylori genotypes may determine gastric histopathology.

[1]  W. Quint,et al.  Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. , 2001, Scandinavian journal of gastroenterology.

[2]  W. Quint,et al.  Helicobacter pylori Genotypes Are Associated with Clinical Outcome in Portuguese Patients and Show a High Prevalence of Infections with Multiple Strains , 2001 .

[3]  S. Misra,et al.  A topographic study of Helicobacter pylori density, distribution and associated gastritis , 2000, Journal of gastroenterology and hepatology.

[4]  B. C. Wong,et al.  Differences in Genotypes of Helicobacter pylori from Different Human Populations , 2000, Journal of bacteriology.

[5]  T. Azuma,et al.  Distinctiveness of Genotypes of Helicobacter pylori in Calcutta, India , 2000, Journal of bacteriology.

[6]  M. Blaser,et al.  Genetic organization and heterogeneity of the iceA locus of Helicobacter pylori. , 2000, Gene.

[7]  M. Blaser,et al.  Distinct Variants of Helicobacter pylori cagA Are Associated with vacA Subtypes , 1999, Journal of Clinical Microbiology.

[8]  D. Graham,et al.  Helicobacter pylori infection is the primary cause of gastric cancer. , 2000, Journal of gastroenterology.

[9]  A. Lastovica,et al.  Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa? , 1999, Gut.

[10]  J. Reguła,et al.  VacA genotyping directly from gastric biopsy specimens and estimation of mixed Helicobacter pylori infections in patients with duodenal ulcer and gastritis. , 1999, Scandinavian journal of gastroenterology.

[11]  M. Blaser,et al.  Distinct Variants of Helicobacter pylori cagA Are Associated with vacA Subtypes , 1999, Journal of Clinical Microbiology.

[12]  D. Graham,et al.  Relationship between Helicobacter pylori iceA, cagA, and vacA Status and Clinical Outcome: Studies in Four Different Countries , 1999, Journal of Clinical Microbiology.

[13]  M. Achtman,et al.  Recombination and clonal groupings within Helicobacter pylori from different geographical regions , 2012 .

[14]  F. Mégraud,et al.  Geographic distribution of vacA allelic types of Helicobacter pylori. , 1999, Gastroenterology.

[15]  E. Mendes,et al.  Helicobacter pylori cagA Status and s and m Alleles of vacA in Isolates from Individuals with a Variety of H. pylori-Associated Gastric Diseases , 1998, Journal of Clinical Microbiology.

[16]  B. Rathbone,et al.  The significance of cagA and vacA subtypes of Helicobacter pylori in the pathogenesis of inflammation and peptic ulceration. , 1998, Journal of clinical pathology.

[17]  M. Blaser,et al.  Expanding Allelic Diversity of Helicobacter pylori vacA , 1998, Journal of Clinical Microbiology.

[18]  R. Rappuoli,et al.  The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Quint,et al.  Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. , 1998, Gastroenterology.

[20]  W. Quint,et al.  Typing of Helicobacter pylori vacA Gene and Detection of cagA Gene by PCR and Reverse Hybridization , 1998, Journal of Clinical Microbiology.

[21]  T. Azuma,et al.  The role of the HLA‐DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection , 1998, Cancer.

[22]  D. Albanes,et al.  Gastric Cancer and Premalignant Lesions in Atrophic Gastritis: A Controlled Trial on the Effect of Supplementation with Alpha-Tocopherol and Beta-Carotene , 1998 .

[23]  Y. Shiratori,et al.  Major virulence factors, VacA and CagA, are commonly positive inHelicobacter pylori isolates in Japan , 1998, Gut.

[24]  D. Albanes,et al.  Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group. , 1998, Scandinavian journal of gastroenterology.

[25]  D. Forman,et al.  Helicobacter pylori infection and cancer. , 1998, British medical bulletin.

[26]  M. Blaser,et al.  Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. , 1998, Proceedings of the Association of American Physicians.

[27]  B E Dunn,et al.  Helicobacter pylori , 1997, Clinical microbiology reviews.

[28]  J. Crabtree,et al.  Mucosal chemokines in Helicobacter pylori infection. , 1997, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[29]  M. Blaser.  Ecology of Helicobacter pylori in the human stomach. , 1997, The Journal of clinical investigation.

[30]  D M Parkin,et al.  Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. , 1997, European journal of cancer.

[31]  J. Atherton.  The clinical relevance of strain types of Helicobacter pylori. , 1997, Gut.

[32]  D. Beall.  Classification and Grading of Gastritis: The Updated Sydney System , 1997 .

[33]  M. Blaser,et al.  Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. , 1997, Gastroenterology.

[34]  M. Borodovsky,et al.  cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M F Dixon,et al.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[36]  H. Adami,et al.  The risk of stomach cancer in patients with gastric or duodenal ulcer disease. , 1996, The New England journal of medicine.

[37]  D. Graham,et al.  Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure , 1996, Journal of bacteriology.

[38]  T. Cover.  The vacuolating cytotoxin of Helicobacter pylori , 1996, Molecular microbiology.

[39]  Wotherspoon Ac.  Gastric MALT lymphoma and Helicobacter pylori. , 1996 .

[40]  E. Kuipers,et al.  Helicobacter pylori and gastric carcinogenesis. , 1996, Scandinavian journal of gastroenterology. Supplement.

[41]  A. Wotherspoon,et al.  Gastric MALT lymphoma and Helicobacter pylori. , 1996, The Yale journal of biology and medicine.

[42]  E. Kuipers,et al.  Helicobacter pylori and atrophic gastritis: importance of the cagA status. , 1996, Journal of the National Cancer Institute.

[43]  M. Blaser,et al.  Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori , 1995, The Journal of Biological Chemistry.

[44]  M. Blaser,et al.  Serologic detection of infection with cagA+ Helicobacter pylori strains , 1995, Journal of clinical microbiology.

[45]  M. Blaser,et al.  Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. , 1995, Cancer research.

[46]  D. Graham,et al.  Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. , 1994, Gastrointestinal endoscopy.

[47]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[48]  E. Fontham,et al.  High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. , 1992, The American journal of gastroenterology.

[49]  N. Muñoz,et al.  Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[50]  C. Holcombe.  Helicobacter pylori: the African enigma. , 1992, Gut.

[51]  R. Leunk.  Production of a cytotoxin by Helicobacter pylori. , 1991, Reviews of infectious diseases.

[52]  M. Salimans,et al.  Rapid and simple method for purification of nucleic acids , 1990, Journal of clinical microbiology.

[53]  P. Correa,et al.  A human model of gastric carcinogenesis. , 1988, Cancer research.